The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: Ozempic, Wegovy and Zepbound. “We’ve started having the patient call and ...
A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.